Tumor Markers - Growing Market 2022 - PowerPoint PPT Presentation

About This Presentation
Title:

Tumor Markers - Growing Market 2022

Description:

The research study on Tumor Markers - Growing Market 2022 provides deep information about Tumar Markers and latest news related to it. – PowerPoint PPT presentation

Number of Views:166

less

Transcript and Presenter's Notes

Title: Tumor Markers - Growing Market 2022


1
Tumor Markers - Growing Market 2022
Submitted By Nikki Heinekar
2
What is Tumor Markers
  • Definition
  • A tumor marker is a biomarker found in blood,
    urine, or body tissues that can be elevated by
    the presence of one or more types of cancer.
    There are many different tumor markers, each
    indicative of a particular disease process, and
    they are used in oncology to help detect the
    presence of cancer.

3
  • A tumor marker is a substance that is produced by
    the body in response to cancer, or is produced by
    the cancer itself.
  • Some of these markers are specific to one cancer,
    while others are seen in several types of cancer.
  • These markers are generally used to evaluate the
    patient's response to treatment or to monitor for
    recurrence (return of the cancer after
    treatment).
  • There are non-cancerous conditions that can cause
    markers to be elevated, so these must also be
    considered when interpreting the test results. 

4
Common Tumor Markers
  • CA15-3 is a sensitive tumor marker for breast
    cancer.
  • CA19-9 antigen has been shown to be elevated in
    the blood of some patients with gastrointestinal
    tumors.
  • CA-125 is a useful marker for monitoring disease
    progression in ovarian cancers.
  • PSA is a useful marker for monitoring disease
    progression in prostate cancers.
  • CEA (carcinoembryonic antigen) is useful in
    monitoring patients with various types of
    malignancies, such as gastrointestinal,
    pancreatic, breast, and lung cancers.

5
Latest News Related To Tumor Markers
  • CA 19-9 tumor marker test can help predict
    early-stage pancreatic cancer patients

Only 1 in 5 U.S. pancreatic cancer
patients receive a widely available, inexpensive
blood test at diagnosis that can help predict
whether they are likely to have a better or worse
outcome than average and guide treatment
accordingly
Read More..
6
  • Weight Loss Reduce Levels of Proteins Linked to
    Tumor Growth

The levels of cancer-causing proteins reduced in
the blood of overweight or obese women who lost
weight through diet or a combination of diet and
exercise, according to a new study
Read More..
7
Uses
  • Tumor markers can be used in conjunction with
    other tests (scans, biopsies, etc.) to help
    diagnose a patient who has symptoms suspicious
    for cancer.
  • Some markers can help physicians to determine
    prognosis and treatment.
  • Markers could be used as a screening tool for the
    general public. The goal of a screening test is
    to diagnose cancer early, when it is the most
    treatable and before it has had a chance to grow
    and spread.

8
References
  • http//goo.gl/UiI5qP
  • http//www.news-medical.net/news/20151104/CA-19-9-
    tumor-marker-test-can-help-predict-early-stage-pan
    creatic-cancer-patients.aspx
  • http//www.medindia.net/news/weight-loss-reduce-le
    vels-of-proteins-linked-to-tumor-growth-161702-1.h
    tm
  • http//www.cancercenter.com/treatments/tumor-marke
    rs/
  • http//www.oncolink.org/cancer-treatment/procedure
    s-diagnostic-tests/blood-tests-
    tumor-diagnostic-tests/patient-guide-to-tumor-mark
    ers
Write a Comment
User Comments (0)
About PowerShow.com